|
SETD4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.872600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.452200E-01 |
| Normal-vs-Stage2 |
1.626400E-01 |
| Normal-vs-Stage3 |
3.844600E-01 |
| Normal-vs-Stage4 |
3.955400E-01 |
| Stage1-vs-Stage2 |
7.498200E-02 |
| Stage1-vs-Stage3 |
5.747400E-01 |
| Stage1-vs-Stage4 |
1.627210E-01 |
| Stage2-vs-Stage3 |
4.728100E-02 |
| Stage2-vs-Stage4 |
4.467200E-01 |
| Stage3-vs-Stage4 |
9.440300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.413400E-01 |
| Normal-vs-AfricanAmerican |
5.956400E-02 |
| Normal-vs-Asian |
1.385980E-01 |
| Caucasian-vs-AfricanAmerican |
1.017970E-02 |
| Caucasian-vs-Asian |
1.411190E-01 |
| AfricanAmerican-vs-Asian |
6.896400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.016000E-01 |
| Normal-vs-Female |
5.749200E-01 |
| Male-vs-Female |
2.004200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.155000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.787000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.345400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.181240E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.493600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.146800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.420970E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.980300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.642550E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.356100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.986800E-01 |
| Normal-vs-Grade 2 |
8.390000E-01 |
| Normal-vs-Grade 3 |
8.667200E-01 |
| Normal-vs-Grade 4 |
7.533400E-01 |
| Grade 1-vs-Grade 2 |
4.287200E-01 |
| Grade 1-vs-Grade 3 |
3.906200E-01 |
| Grade 1-vs-Grade 4 |
5.861800E-01 |
| Grade 2-vs-Grade 3 |
9.747800E-01 |
| Grade 2-vs-Grade 4 |
6.015800E-01 |
| Grade 3-vs-Grade 4 |
5.950000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.534600E-01 |
| Normal-vs-ccB subtype |
9.517600E-01 |
| ccA subtype-vs-ccB subtype |
2.087400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.317400E-01 |
| Normal-vs-N1 |
6.380000E-01 |
| N0-vs-N1 |
5.709000E-01 |
|
|
